References
- Baek SM, Kwon CH, Kim JH, et al (2003). Differential roles of hydrogen peroxide and hydroxyl radical in cisplatin-induced cell death in renal proximal tubular epithelial cells. J Lab Clin Med, 142, 178-86. https://doi.org/10.1016/S0022-2143(03)00111-2
- Barr DB, Wilder LC, Caudill SP, et al (2005). Urinary Creatinine Concentrations in the U.S. Population: Implications for Urinary Biologic Monitoring Measurements. Environ Health Perspect, 113, 192-200.
-
Basu S (2008).
$F_{2}$ -isoprostanes in human health and diseases: from molecular mechanisms to clinical implications. Antioxid Redox Signal, 10, 1405-34. https://doi.org/10.1089/ars.2007.1956 - Chirinoa YI, Pedraza-Chaverri J (2009) Role of oxidative and nitrosative stress in cisplatin-induced nephrotoxicity. J Exper Tox Path, 61, 223-42 https://doi.org/10.1016/j.etp.2008.09.003
-
Dalaveris E, Kerenidi T, Katsabeki-Katsafli A, et al (2009). VEGF, TNF-
$\alpha$ and 8-isoprostane levels in exhaled breath condensate and serum of patients with lung cancer. Lung Cancer, 64, 219-25. https://doi.org/10.1016/j.lungcan.2008.08.015 -
Davies SS, Zackert W, Luo Y, et al (2006). Quantification of dinor, dihydro metabolites of
$F_{2}$ -isoprostanes in urine by liquid chromatography/tandem mass spectrometry. Anal Biochem, 348, 185-91. https://doi.org/10.1016/j.ab.2005.10.012 - De Castro J, Hernandez-Hernandez A, Rodriguez MC, Llanillo M, Sanchez-Yague J (2006). Comparison of changes in erythrocyte and platelet fatty acid composition and protein oxidation in advanced non-small cell lung cancer. Cancer Invest, 24, 339-45. https://doi.org/10.1080/07357900600705250
- Fabbro ED, Dalal S, Bruera E (2006). Symptom Control in Palliative Care-Part II: Cachexia/Anorexia and Fatigue. J Pall Med, 9, 409-21. https://doi.org/10.1089/jpm.2006.9.409
- Garde AH, Hansen AM, Kristiansen J, Knudsen LE (2004). Comparison of Uncertainties Related to Standardization of Urine Samples with Volume and Creatinine Concentration. Ann Occup Hyg, 48, 171-9. https://doi.org/10.1093/annhyg/meh019
- Gupta A, Srivastava S, Prasad R, et al (2010). Oxidative stress in non-small cell lung cancer patients after chemotherapy: association with treatment response. Respirology, 15, 349- 56. https://doi.org/10.1111/j.1440-1843.2009.01703.x
-
Helmersson J, Basu S (1999).
$F_{2}$ -isoprostane excretion rate and diurnal variation in human urine. Prostaglandins Leukot Essent Fatty Acids, 61, 203-5. https://doi.org/10.1054/plef.1999.0091 - Il'yasova D, Kennedy K, Spasojevic I, et al (2010). Individual responses to chemotherapy-induced oxidative stress. Breast Cancer Res Treat, 125, 583-9.
- Janssen LJ (2001). Isoprostanes: an overview and putative roles in pulmonary pathophysiology. Am J Physiol Lung Cell Mol Physiol, 280, 1067-82. https://doi.org/10.1152/ajplung.2001.280.6.L1067
- Janssen LJ (2008). Isoprostanes and lung vascular pathology. Am J Respir Cell Mol Biol, 39, 383-9. https://doi.org/10.1165/rcmb.2008-0109TR
- Kadiiska MB, Gladen BC, Baird DD, et al (2005). Biomarkers of oxidative stress study II: are oxidation products of lipids, proteins, and DNA markers of CCl4 poisoning? Free Radic Biol Med, 38, 698-710. https://doi.org/10.1016/j.freeradbiomed.2004.09.017
- Kannan K, Jain SK (2000). Oxidative stress and apoptosis. Pathophysiology, 7, 153-63. https://doi.org/10.1016/S0928-4680(00)00053-5
- Liang Y, Wei P, Duke RW, et al (2003). Quantification of 8-isoprostaglandin- F(2alpha) and 2,3-dinor-8-iso-prostaglandin- F(2alpha) in human urine using liquid chromatographytandem mass spectrometry. Free Radic Biol Med, 34, 409-18. https://doi.org/10.1016/S0891-5849(02)01018-3
- Lieberthal W, Triaca V, Levine J (1996). Mechanisms of death induced by cisplatin in proximal tubular epithelial cells: apoptosis vs. necrosis. Am J Physiol, 270, 700-8.
- Montuschi P, Barnes PJ, Roberts LJ (2004). Isoprostanes: markers and mediators of oxidative stress. FASEB J, 18, 1791-800. https://doi.org/10.1096/fj.04-2330rev
- Montuschi P, Barnes PJ, Roberts LJ (2007). Insights into oxidative stress: the isoprostanes. Curr Med Chem, 14,703- 17. https://doi.org/10.2174/092986707780059607
- Moore K, Roberts LJ (1998). Measurement of lipid peroxidation. Free Radic Res, 28,659-71. https://doi.org/10.3109/10715769809065821
-
Morrow JD, Hill KE, Burk RF, et al (1990). A series of prostaglandin
$F_{2}$ -like compounds are produced in vivo in humans by a non-cyclooxygenase free radical catalyzed mechanism. Proc Natl Acad Sci USA, 87, 9383-7. https://doi.org/10.1073/pnas.87.23.9383 - Morrow JD, Harris TM, Roberts LJ (1990). Noncyclooxygenase oxidative formation of a series of novel prostaglandins: analytical ramifications for measurement of eicosanoids. Anal Biochem, 184,1-10.Roberts LJ & Morrow JD (2000). Measurement of F(2)-isoprostanes as an index of oxidative stress in vivo. Free Radic Biol Med, 28, 505-13. https://doi.org/10.1016/S0891-5849(99)00264-6
- Morrow JD, Roberts LJ (1994). Mass spectrometry of prostanoids: F2-isoprostanes produced by non-cyclooxygenase free radical-catalyzed mechanism. Methods Enzymol, 233, 163-74. https://doi.org/10.1016/S0076-6879(94)33019-0
- Morrow JD, Roberts LJ (1996). The isoprostanes. Current knowledge and directions for future research. Biochem Pharmacol, 51, 1-9. https://doi.org/10.1016/0006-2952(95)02072-1
-
Salahudeen A, Poovala V, Parry W, et al (1998). Cisplatin induces N-acetyl cysteine suppressible
$F_{2}$ -isoprostane production and injury in renal tubular epithelial cells. J Am Soc Nephrol, 9, 1448-55. - Srivastava AN, Gupta A, Srivastava S, et al (2010). Cisplatin combination chemotherapy induces oxidative stress in advance non small cell lung cancer patients. APJCP, 11, 465-71.
- Villanueva MT (2011). Targeted therapies: Evolve and ... surrender! Nature Rev Clin Oncol, 8, 315.
- Yan W, Byrd GD, Ogden MW (2007). Quantitation of isoprostane isomers in human urine from smokers and nonsmokers by LC-MS/MS. J Lipid Res, 48, 1607-17. https://doi.org/10.1194/jlr.M700097-JLR200
-
Zhang B, Saku K (2007). Control of matrix effects in the analysis of urinary
$F_{2}$ -isoprostanes using novel multidimensional solid-phase extraction and LC-MS/MS. J Lipid Res, 48, 733-44. https://doi.org/10.1194/jlr.D600040-JLR200 - Zieba M, Nowak D, Suwalski M, et al. (2001). Enhanced lipid peroxidation in cancer tissue homogenates in non-small cell lung cancer. Monaldi Arch Chest Dis, 56, 110-4.
Cited by
- Pu-erh Tea Powder Preventive Effects on Cisplatin-Induced Liver Oxidative Damage in Wistar Rats vol.15, pp.17, 2014, https://doi.org/10.7314/APJCP.2014.15.17.7389
- Effect of Zinc Supplementation on Antioxidant Defenses and Oxidative Stress Markers in Patients Undergoing Chemotherapy for Colorectal Cancer: a Placebo-Controlled, Prospective Randomized Trial vol.169, pp.1, 2016, https://doi.org/10.1007/s12011-015-0396-2
- Elevated exhalation of hydrogen peroxide in patients with non-small cell lung cancer is not affected by chemotherapy vol.22, pp.6, 2017, https://doi.org/10.1080/13510002.2016.1229885
- Nuclear magnetic resonance- and mass spectrometry-based metabolomics to study maleic acid toxicity from repeated dose exposure in rats vol.37, pp.12, 2017, https://doi.org/10.1002/jat.3500